Washington, DC —Recently, the influenza A/H1N1 pandemic of 2009 to 2010 was the talk of the presidential campaign. That severe influenza season raised the question of whether some flu virus strains are inherently more dangerous than others.
As a result, many studies have described the clinical course and outcome of the different subtypes of influenza—A/H1N1, A/H3N2 and B. New research from the U.S. Department of Defense (DoD), however, identified no appreciable differences, in either clinical presentation or disease severity among the subtypes.
The report in Military Medicine caution that study parameters limit the applicability of the results to military populations.
Madigan Army Medical Center–led researchers sought to evaluate differences in disease severity among influenza subtypes in a cohort of healthy, primarily outpatient adult U.S. DoD beneficiaries. To do that, the study team enrolled otherwise healthy adults up to age 65 years with influenza-like illness in an observational cohort study based in five U.S. military medical centers from 2009 to 2014. Researchers collected serial nasopharyngeal swabs for determination of etiology and viral shedding by polymerase chain reaction. At the same time, the presence and severity of symptoms was assessed by interview and patient diary.
Over the study period, 157 adults with laboratory-confirmed influenza and influenza subtype were enrolled—44% were positive for influenza A(H1N1), 44% for influenza A(H3N2) and 12% for influenza B. Most, about 61%, participants were male, 64% were active-duty military personnel, and 72% had received influenza vaccine in the past 8 months. Hospitalization occurred in almost 10% of the group.
“Seasonal influenza virus distribution among enrollees mirrored that of nationwide trends each year of study,” according to the authors, who explain that patients with A/H1N1 had upper respiratory composite scores that were lower than those with A/H3N2.
Overall, multivariate models indicate that individuals with A(H1N1) and B had increased lower respiratory symptom scores when compared with influenza A(H3N2) (A[H1N1]: 1.51 [95% CI, 0.47-2.55]; B: 1.46 [95% CI, 0.09-2.83]). Other than that, the researchers point out, no other differences in symptom severity scores among influenza A(H1N1), influenza A(H3N2), and influenza B infection were observed.
The study team adds that influenza season—peaking in the 2012-2013 season—and female sex were found to be associated with increased influenza symptom severity.
“Our study of influenza in a cohort of otherwise healthy, outpatient adult Department of Defense beneficiaries over [five] influenza seasons revealed few differences between influenza A(H1N1), influenza A(H3N2), and influenza B infection with respect to self-reported disease severity or clinical outcomes,” researchers concluded. “This study highlights the importance of routine, active, and laboratory-based surveillance to monitor ongoing trends and severity of influenza in various populations to inform prevention measures.”
The content contained in this article is for informational purposes only. The content is not intended to be a substitute for professional advice. Reliance on any information provided in this article is solely at your own risk.